Christoph Bidlingmaier

ORCID: 0000-0003-3755-0930
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hemophilia Treatment and Research
  • Blood Coagulation and Thrombosis Mechanisms
  • Platelet Disorders and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Cancer-related gene regulation
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Acute Ischemic Stroke Management
  • Cardiovascular Issues in Pregnancy
  • Emergency and Acute Care Studies
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac, Anesthesia and Surgical Outcomes
  • Inflammatory Bowel Disease
  • Sepsis Diagnosis and Treatment
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Pneumonia and Respiratory Infections
  • Immunodeficiency and Autoimmune Disorders
  • Pregnancy and Medication Impact
  • Gastroesophageal reflux and treatments
  • Health and Medical Studies
  • Respiratory viral infections research
  • Neonatal and Maternal Infections
  • Blood properties and coagulation

Ludwig-Maximilians-Universität München
2015-2025

München Klinik
2008-2025

National and Kapodistrian University of Athens
2023

Imperial College London
2023

LMU Klinikum
2008-2022

Ostschweizer Kinderspital
2005-2021

University of Milan
2017

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2017

Ospedale Maggiore
2017

Hemophilia Center of Iran
2013

The relative importance of previous diagnosis and hereditary prothrombotic risk factors for cerebral venous thrombosis (CVT) in children determining a second or systemic (VT), compared with other clinical, neuroimaging, treatment variables, is unknown.We followed up the survivors 396 consecutively enrolled patients CVT, aged newborn to 18 years (median 5.2 years) median 36 months (maximum 85 months). In accordance international guidelines, 250 (65%) received acute anticoagulation...

10.1016/s1474-4422(07)70131-x article EN cc-by The Lancet Neurology 2007-06-08

Summary. The most problematic complication of haemophilia A treatment is the development inhibitors to FVIII. highest risk developing during first 20 exposure days (EDs). If patient can be brought through this high period without inhibitor development, subsequent low. Therefore, as a pilot project, we developed prophylaxis regimen for 20–50 EDs specifically designed induce tolerance administered FVIII and minimize by avoiding immunological danger signals. Twenty‐six consecutive previously...

10.1111/j.1365-2516.2009.02122.x article EN Haemophilia 2009-10-30

The specific type IV phosphodiesterase inhibitor rolipram is a potent suppressor of tumor necrosis factor-alpha (TNF) synthesis. We examined the efficacy for prevention and treatment experimental colitis. To induce colitis, BALB/c mice received 5% dextran sulfate sodium in their drinking water continuously up to 11 days. Colitis was quantified by clinical activity score assessing weight loss, stool consistency, rectal bleeding (range from 0 4); colon length; semiquantitative histologic 6);...

10.1016/s0022-3565(24)35257-7 article EN Journal of Pharmacology and Experimental Therapeutics 2000-02-01

Introduction There has been increasing recognition in recent years that female carriers of haemophilia manifest abnormal bleeding; however, data on the use bleeding assessment tools this population are lacking. Aim Our objective was to validate ISTH ‐ BAT describe symptoms and allow for comparisons with factor levels other patient groups. Methods This a prospective, observational, cross‐sectional study performed by members Global Emerging HE mostasis Panel ( GEHEP ). Unselected consecutive...

10.1111/hae.13089 article EN Haemophilia 2016-11-01

Adenosine is a potent anti-inflammatory mediator. Through elevation of endogenous adenosine concentrations the kinase inhibitor GP515 might serve to down-regulate local inflammatory responses. In present study we investigated effect systemic in nonacute model dextran sulfate sodium (DSS)-induced colitis. The clinical score, colon length, histologic cytokine production, and spleen weight from mice with DSS-induced colitis (3.5% DSS drinking water for 11 days) receiving treatment were...

10.1016/s0022-3565(24)29668-3 article EN Journal of Pharmacology and Experimental Therapeutics 2001-01-01

Summary. Severe haemophilia is associated with recurrent joint bleeds, which can lead to haemophilic arthropathy. Subclinical bleeds have also been damage detected using magnetic resonance imaging (MRI). We investigated the development of early changes in clinically asymptomatic joints MRI A or B patients receiving prophylactic therapy. In this single‐centre retrospective cohort study, clinical evidence one ankle and ankle, we performed an scan both ankles session, were enrolled. findings...

10.1111/j.1365-2516.2011.02682.x article EN Haemophilia 2011-10-28

Summary Sparse data are available on presentation and management of acute coronary syndromes ( ACS ), including unstable angina non‐ ST ‐ ‐elevation myocardial infarction, among persons with haemophilia PWH ). The aim this study was to determine demographics, bleeding disorder characteristics, cardiovascular risk factors CRF s), interventions, haemostatic protocol, revascularization outcomes complications . Members an international consortium comprising >2000 adult retrospectively...

10.1111/hae.12652 article EN Haemophilia 2015-02-17

Background Refugee children and young people have complex healthcare needs. However, issues related to acute provision for refugee across Europe remain unexplored. This study aimed describe the urgent emergency needs of in Europe, identify obstacles providing this care. Methods An online cross-sectional survey was distributed European professionals via research networks between 1 February October 2017 addressing health aged <18 years fulfilling international criteria status, presenting...

10.1136/emermed-2019-208699 article EN cc-by-nc Emergency Medicine Journal 2020-09-09

The present multicenter cohort study of 107 pediatric PUPs was performed to determine whether the concomitant inheritance factor (F) V G1691A or F II G20210A mutation influences clinical expression severe hemophilia A (HA). Carriers FV and FII mutations had a significantly lower annual bleeding frequency (ABF) than non-carriers (p=0.012). Joint damage (Pettersson score) less in patients with thrombophilia (p=0.022). protective effect thrombophilic risk factors shown for ABF (OR [CIs]:...

10.3324/haematol.11161 article EN cc-by-nc Haematologica 2007-07-01
Dorine Borensztajn Joany M. Zachariasse Enitan D. Carrol Ruud Nijman Ulrich von Both and 95 more Marieke Emonts Jethro Herberg Benno Kohlmaier Michael Levin Emma Lim Ian Maconochie Federico Martinón‐Torres Marko Pokorn Irene Rivero‐Calle Aleksandra Rudzāte Chantal Tan Μαρία Τσολιά Clementien Vermont Dace Zavadska Werner Zenz Henriëtte A. Moll Nienke N. Hagedoorn Willem A. Dik Stéphane Paulus Elizabeth Cocklin Rebecca B. Jennings Joanne Johnston Simon Leigh Karen Newall Sam Romaine Aubrey J. Cunnington Tisham De Myrsini Kaforou Victoria Wright Lucas Baumard Evangelos Bellos Giselle D’Souza Rachel Galassini Dominic Habgood-Coote Shea Hamilton Clive Hoggart Sara Hourmat Heather Jackson Stephanie Menikou Naomi Lin Samuel Nichols Ivonne Pena Paz Priyen Shah Ching‐Fen Shen Ortensia Vito Clare Wilson Amina Abdulla Ladan Ali Sarah Darnell Rikke Jørgensen Sobia Mustafa Salina Persand Laura Kolberg Manuela Zwerenz Judith Buschbeck Christoph Bidlingmaier Vera Binder Katharina Danhauser Nikolaus Haas Matthias Griese Tobias Feuchtinger Julia Keil Matthias Kappler Eberhard Lurz Georg Muench Karl Reiter Carola Schoen Lucille Valentine Karen N. Allen Kathryn Bell Adora Chan Stephen Crulley Kirsty Devine Daniel Fabián Sharon King Paul McAlinden Sam McDonald Anne McDonnell Ailsa Pickering E. Thomson Amanda Wood Diane Wallia Phil Woodsford Frances Baxter Ashley Bell Mathew Rhodes Rachel Agbeko Christine Mackerness Bryan Baas Lieke Kloosterhuis Wilma Oosthoek Tasnim Arif Joshua Bennet Kalvin Collings Ilona van der Giessen

Abstract Background Studies on procalcitonin (PCT) for identifying sepsis were published as early 1993 and since then, PCT has been the topic of over 8,500 studies. Several studies show to be superior CRP in differentiating invasive infections such from viral infections, especially disease course. However, its actual use clinical practice is poorly documented. Our aim was study febrile children attending ED across Europe compare this CRP. Methods The MOFICHE/PERFORM study, a prospective...

10.1186/s12887-025-05483-1 article EN cc-by BMC Pediatrics 2025-03-01

10.1007/s00112-025-02169-x article DE Monatsschrift Kinderheilkunde 2025-03-17
Coming Soon ...